Yuji Hidaka - Concepedia

Author

Yuji Hidaka

Japanese Red Cross Kumamoto Hospital ORCID

Also Known As

Amato de Paulis, Hidaka, Yoshiki, Y HIDAKA, Y Hidaka, Y. HIDAKA, Y. Hidaka, Yoh Hidaka, Yuji HIDAKA, Yuji Hidaka

Publications

812

Citations

H-Index

Concepts

All Affiliations

Japanese Red Cross Kumamoto Hospital Jikei University School of Medicine The University of Osaka Tokyo Women's Medical University Mochida Pharmaceutical (Japan)

About

Yuji Hidaka is an author at Japanese Red Cross Kumamoto Hospital specializing in medicine, kidney transplant, and longevity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	88
2	Public Health	1	1	19
3	Allergy	1	1	47
4	Epidemiology	1	1	19
5	Geriatrics	1	1	22

Yuji Hidaka

Publications

557

Citations

H-Index

Page 1

	Year	Citations
Effects of Autoantibodies on the Course of Pregnancy and Fetal Growth Toru Iijima, Hirokazu Tada, Yuji Hidaka, Obstetrics and Gynecology	1997	146
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study Hisashi Yamanaka, Shigenori Tamaki, Yumiko Ide, Annals of the Rheumatic Diseases	2017	118
Attempted suicide, psychological health and exposure to harassment among Japanese homosexual, bisexual or other men questioning their sexual orientation recruited via the internet Yuji Hidaka, Don Operario Journal of Epidemiology & Community Health	2006	64
Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease. Yuji Hidaka, Nobuyuki Amino, Yoshinori Iwatani, The Journal of Clinical Endocrinology & Metabolism AsthmaAllergyAutoimmune DiseasePeripheral EosinophilsThyrotoxicosis Relapse	1993	47
Decreases in αβ T cell receptor negative T cells and CD8 cells, and an increase in CD4 +CD8+ cells in active Hashimoto's disease and subacute thyroiditis Yoshinori Iwatani, Nobuyuki Amino, Yuji Hidaka, Clinical & Experimental Immunology	1992	43
Prediction model of compensation for contralateral kidney after living-donor donation Kenji Okumura, Shigeyoshi Yamanaga, Kosuke Tanaka, BMC Nephrology	2019	24
Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials Toshinari Takahashi, Takanobu Beppu, Yuji Hidaka, Clinical and Experimental Hypertension	2021	24
Long-Term Safety of Living Kidney Donors Aged 60 and Older Mariko Toyoda, Shigeyoshi Yamanaga, Chiaki Kawabata, Transplantation Proceedings Renal CareUrologyKidney TransplantGeriatricsLongevity	2014	22
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic Shigeyoshi Yamanaga, Keita Shimata, Satoko Ohfuji, American Journal of Transplantation Solid Organ TransplantationTransplantation MedicineCovid-19 EpidemiologyCovid-19Clinical Epidemiology	2024	19
Factors related to suboptimal recovery of renal function after living donor nephrectomy: a retrospective study Sho Nishida, Yuji Hidaka, Mariko Toyoda, BMC Nephrology	2019	14

Page 1